Jin-Hee Ahn Selected Research

Jin-Hee Ahn Research Topics

Disease

73	Breast Neoplasms (Breast Cancer) 12/2022 - 06/2004
47	Neoplasms (Cancer) 12/2022 - 06/2004
13	Renal Cell Carcinoma (Grawitz Tumor) 04/2016 - 10/2010
12	Neoplasm Metastasis (Metastasis) 12/2021 - 07/2011
10	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 12/2011
9	Triple Negative Breast Neoplasms 10/2022 - 07/2011
8	Pathologic Complete Response 01/2022 - 06/2012
7	Disease Progression 04/2022 - 10/2012
5	Stomach Neoplasms (Stomach Cancer) 01/2021 - 08/2002
4	Neutropenia 01/2021 - 05/2012
3	Pain (Aches) 08/2020 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015 - 08/2004
3	Residual Neoplasm 06/2015 - 05/2014
2	Aggressive Fibromatosis (Desmoid) 10/2022 - 05/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2003
2	Leiomyosarcoma 01/2022 - 01/2018
2	Circulating Neoplastic Cells 03/2021 - 10/2020
2	Emergence Delirium 08/2020 - 01/2020
2	Hand-Foot Syndrome 01/2019 - 10/2004
2	Tertiary Lymphoid Structures 12/2015 - 08/2015
2	Adenocarcinoma 10/2015 - 03/2010
2	Carcinoma (Carcinomatosis) 08/2015 - 10/2012
2	Amenorrhea 09/2013 - 01/2011
2	Rectal Neoplasms (Rectal Cancer) 11/2011 - 04/2002
2	Brain Neoplasms (Brain Tumor) 07/2011 - 10/2008
2	Prostatic Neoplasms (Prostate Cancer) 04/2011 - 03/2010
1	Margins of Excision 04/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2022
1	Liposarcoma 01/2022

Drug/Important Bio-Agent (IBA)

18	Hormones (Hormone)IBA 04/2022 - 03/2010
15	Docetaxel (Taxotere)FDA Link 01/2022 - 10/2004
13	Trastuzumab (Herceptin)FDA Link 01/2022 - 04/2012
13	AnthracyclinesIBA 01/2019 - 08/2004
11	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 01/2009
10	ErbB Receptors (EGF Receptor)IBA 04/2022 - 08/2004
10	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2012
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2015
9	Gemcitabine FDA Link 01/2022 - 03/2012
9	human ERBB2 proteinIBA 08/2021 - 04/2012
8	Estrogen ReceptorsIBA 12/2022 - 06/2011
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 02/2005
7	Everolimus FDA Link 04/2022 - 12/2013
7	taxaneIBA 01/2021 - 08/2004
6	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2009
6	Cisplatin (Platino)FDA LinkGeneric 10/2012 - 08/2002
5	Carboplatin (JM8)FDA LinkGeneric 10/2022 - 02/2005
5	Letrozole (Femara)FDA LinkGeneric 05/2021 - 10/2016
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2016 - 04/2012
5	Sunitinib (Sutent)FDA Link 09/2013 - 01/2009
4	Tamoxifen FDA LinkGeneric 04/2021 - 08/2016
4	Lapatinib (GW572016)FDA Link 10/2020 - 10/2016
4	Epidermal Growth Factor (EGF)IBA 10/2020 - 07/2011
4	Vinorelbine (Navelbine)FDA LinkGeneric 12/2019 - 08/2004
4	Capecitabine (Xeloda)FDA Link 01/2019 - 08/2004
4	Angiogenesis InhibitorsIBA 12/2017 - 01/2014
4	Progesterone Receptors (Progesterone Receptor)IBA 10/2014 - 06/2004
3	eribulin FDA Link 01/2022 - 11/2017
3	pertuzumabIBA 01/2022 - 12/2018
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2016
3	Phenobarbital (Luminal)FDA Link 12/2021 - 05/2014
3	Pharmaceutical PreparationsIBA 01/2019 - 05/2012
3	thiamine triphosphorate (TTP)IBA 11/2018 - 08/2014
3	orantinib (SU6668)IBA 12/2017 - 08/2014
2	Indicators and Reagents (Reagents)IBA 10/2022 - 06/2012
2	Leuprolide (Lupron)FDA LinkGeneric 05/2021 - 01/2021
2	Alanine Transaminase (SGPT)IBA 01/2021 - 08/2016
2	CytokinesIBA 01/2021 - 06/2015
2	Zoledronic Acid (Zometa)FDA Link 01/2021 - 01/2011
2	Fulvestrant (Faslodex)FDA Link 11/2018 - 06/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2015
2	HLA-A Antigens (HLA-A)IBA 05/2016 - 08/2015
2	ParaffinIBA 03/2016 - 06/2004
2	Gefitinib (Iressa)FDA Link 10/2015 - 06/2013
2	Ifosfamide FDA LinkGeneric 12/2013 - 03/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012 - 01/2012
2	Estrogens (Estrogen)FDA Link 06/2012 - 06/2004
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 06/2005 - 02/2005
2	Fluorouracil (Carac)FDA LinkGeneric 02/2003 - 08/2002
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Imatinib Mesylate (Gleevec)FDA Link 10/2022
1	CateninsIBA 10/2022
1	Epirubicin (Ellence)FDA LinkGeneric 10/2022
1	pembrolizumabIBA 10/2022
1	B7-H1 AntigenIBA 04/2022
1	Cyclin-Dependent Kinase 4IBA 04/2022
1	trastuzumab deruxtecanIBA 02/2022
1	atezolizumabIBA 01/2022

Therapy/Procedure

36	Drug Therapy (Chemotherapy) 10/2022 - 04/2002
24	Therapeutics 10/2022 - 04/2002
23	Neoadjuvant Therapy 10/2022 - 06/2012
13	Adjuvant Chemotherapy 01/2022 - 06/2004
12	Radiotherapy 04/2022 - 04/2002
6	Combination Drug Therapy (Combination Chemotherapy) 11/2017 - 10/2004
3	Immunotherapy 01/2022 - 05/2013
3	Nephrectomy 05/2013 - 01/2011
2	Mastectomy (Mammectomy) 01/2022 - 12/2021
2	Anesthesia 08/2020 - 01/2020
2	Maintenance Chemotherapy 07/2015 - 05/2013
2	Stem Cell Transplantation 06/2005 - 02/2005
1	Mammaplasty (Breast Reconstruction) 01/2022